Skip to main content
Top
Published in: International Urogynecology Journal 2/2011

01-02-2011 | Original Article

Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study

Authors: Philippe Sèbe, Christelle Doucet, Jean-Nicolas Cornu, Calin Ciofu, Pierre Costa, Sixtina Gil Diez de Medina, Christian Pinset, Francois Haab

Published in: International Urogynecology Journal | Issue 2/2011

Login to get access

Abstract

Introduction and hypothesis

Cell therapy for stress urinary incontinence (SUI) management has been experienced with encouraging results.

Methods

We conducted an open prospective study on 12 women presenting severe SUI with fixed urethra, after previous failed surgical management. Patients underwent intrasphincteric injections of autologous progenitor muscular cells isolated from a biopsy of deltoid muscle. Primary endpoint focused on safety (measurement of Q max variation after 3 months). Secondary endpoints assessed side effects and efficacy.

Results

No variation was diagnosed on Q max measurements. Efficacy data show that three of 12 patients are dry at 12 months, seven other patients are improved on pad test but not on voiding diary, and two patients were slightly worsened by the procedure. Quality of life was improved in half of patients.

Conclusions

Cell therapy for severe multioperated cases of SUI is a mini-invasive, feasible, and safe procedure that can improve urinary condition in as a second line therapy.
Literature
1.
go back to reference Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2003) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49CrossRefPubMed Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2003) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49CrossRefPubMed
3.
go back to reference Pajoncini C, Costantini E, Guercini F, Bini V, Porena M (2003) Clinical and urodynamic features of intrinsic sphincter deficiency. Neurourol Urodyn 22:264–268CrossRefPubMed Pajoncini C, Costantini E, Guercini F, Bini V, Porena M (2003) Clinical and urodynamic features of intrinsic sphincter deficiency. Neurourol Urodyn 22:264–268CrossRefPubMed
4.
go back to reference Haab F, Zimmern PE, Leach GE (1996) Female stress urinary incontinence due to intrinsic sphincteric deficiency: recognition and management. J Urol 156:3–17CrossRefPubMed Haab F, Zimmern PE, Leach GE (1996) Female stress urinary incontinence due to intrinsic sphincteric deficiency: recognition and management. J Urol 156:3–17CrossRefPubMed
5.
go back to reference Shamliyan TA, Kane RL, Wyman J, Wilt TJ (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148:459–473PubMed Shamliyan TA, Kane RL, Wyman J, Wilt TJ (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148:459–473PubMed
6.
go back to reference Mariappan P, Alhasso A, Ballantyne Z, Grant A, N’Dow J (2007) Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 51:67–74CrossRefPubMed Mariappan P, Alhasso A, Ballantyne Z, Grant A, N’Dow J (2007) Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 51:67–74CrossRefPubMed
7.
go back to reference Wilson TS, Lemack GE, Zimmern PE (2003) Management of intrinsic sphincteric deficiency in women. J Urol 169:1662–1669CrossRefPubMed Wilson TS, Lemack GE, Zimmern PE (2003) Management of intrinsic sphincteric deficiency in women. J Urol 169:1662–1669CrossRefPubMed
8.
go back to reference Kiilholma P, Chancellor MB, Makinen J, Hirsch IH, Klemi PJ (1993) Complications of Teflon injections for stress urinary incontinence. Neurourol Urodyn 12:131–137CrossRefPubMed Kiilholma P, Chancellor MB, Makinen J, Hirsch IH, Klemi PJ (1993) Complications of Teflon injections for stress urinary incontinence. Neurourol Urodyn 12:131–137CrossRefPubMed
10.
11.
go back to reference Torrente Y, Belicchi M, Marchesi C, Dantona G, Cogiamanian F, Pisati F et al (2007) Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 16:563–577PubMed Torrente Y, Belicchi M, Marchesi C, Dantona G, Cogiamanian F, Pisati F et al (2007) Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 16:563–577PubMed
12.
go back to reference Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D et al (2001) Myoblast transplantation for heart failure. Lancet 357:279–280CrossRefPubMed Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D et al (2001) Myoblast transplantation for heart failure. Lancet 357:279–280CrossRefPubMed
13.
go back to reference Strasser H, Berjukow S, Marksteiner R, Margreiter E, Hering S, Bartsch G et al (2004) Stem cell therapy for urinary stress incontinence. Exp Gerontol 39:1259–1265CrossRefPubMed Strasser H, Berjukow S, Marksteiner R, Margreiter E, Hering S, Bartsch G et al (2004) Stem cell therapy for urinary stress incontinence. Exp Gerontol 39:1259–1265CrossRefPubMed
14.
go back to reference Praud C, Sebe P, Biérinx AS, Sebille A (2007) Improvement of urethral sphincter deficiency in female rats following autologous skeletal muscle myoblasts grafting. Cell Transplant 16:741–749PubMed Praud C, Sebe P, Biérinx AS, Sebille A (2007) Improvement of urethral sphincter deficiency in female rats following autologous skeletal muscle myoblasts grafting. Cell Transplant 16:741–749PubMed
15.
go back to reference Peyromaure M, Sèbe P, Praud C, DeRocle G, Potin N, Pincet C et al (2004) Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: perspectives for treatment of urinary incontinence. Urology 64:1037–1041CrossRefPubMed Peyromaure M, Sèbe P, Praud C, DeRocle G, Potin N, Pincet C et al (2004) Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: perspectives for treatment of urinary incontinence. Urology 64:1037–1041CrossRefPubMed
16.
go back to reference Yiou R, Yoo JJ, Atala A (2003) Restoration of functional motor units in a rat model of sphincter injury by muscle progenitor cell autografts. Transplantation 76:1053–1060CrossRefPubMed Yiou R, Yoo JJ, Atala A (2003) Restoration of functional motor units in a rat model of sphincter injury by muscle progenitor cell autografts. Transplantation 76:1053–1060CrossRefPubMed
17.
go back to reference Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser MO, Kumon H et al (2001) Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 165:271–276CrossRefPubMed Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser MO, Kumon H et al (2001) Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 165:271–276CrossRefPubMed
18.
go back to reference Chancellor MB, Yokoyama T, Tirney S, Mattes CE, Ozawa H, Yoshimura N et al (2000) Preliminary results of myoblasts injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractibility. Neurourol Urodyn 19:279–287CrossRefPubMed Chancellor MB, Yokoyama T, Tirney S, Mattes CE, Ozawa H, Yoshimura N et al (2000) Preliminary results of myoblasts injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractibility. Neurourol Urodyn 19:279–287CrossRefPubMed
19.
go back to reference Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R et al (2008) 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:881–883CrossRefPubMed Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R et al (2008) 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:881–883CrossRefPubMed
20.
go back to reference Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F (2003) European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol 43:391–404CrossRefPubMed Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F (2003) European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol 43:391–404CrossRefPubMed
21.
go back to reference Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B et al (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12:1130–1141CrossRefPubMed Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B et al (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12:1130–1141CrossRefPubMed
Metadata
Title
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study
Authors
Philippe Sèbe
Christelle Doucet
Jean-Nicolas Cornu
Calin Ciofu
Pierre Costa
Sixtina Gil Diez de Medina
Christian Pinset
Francois Haab
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue 2/2011
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-010-1255-5

Other articles of this Issue 2/2011

International Urogynecology Journal 2/2011 Go to the issue